We are joined by experts who share what you need to know to protect your kidneys, including the importance of early detection ...
The SLE and LN market offers opportunities with the launch of 10 late-stage pipeline drugs improving safety and efficacy, contrasting with the current generic treatments. However, growth is challenged ...
Biogen announced positive results from the Phase 2 part of the AMETHYST Phase 2/3 study (part A) of investigational therapy, ...
Systemic Lupus Erythematosus Clinical Trial Pipeline Accelerates as 120+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight The SLE clinical trial analysis report delivers ...
In light of litifilimab recently receiving FDA Breakthrough Therapy Designation for CLE, we spoke with experts to discuss diagnostic and treatment gaps in disease management. Cutaneous lupus ...
Litifilimab was superior to placebo for reducing skin disease activity in cutaneous lupus erythematosus, according to phase 2 ...
CAR-T therapy is toting up more remissions in autoimmune disease, and generating a flood of experimentation and investment.
Italian researchers reporting in the journal Cancers found a 32% increase in the odds for cancer in the first year after a ...
Selena Gomez’s case raises real questions about lupus, transplants, and whether a safe pregnancy is possible.
Investigators studied GLP-1 receptor agonist use and renal and inflammatory outcomes among patients with systemic lupus erythematosus and type 2 diabetes mellitus.
The Coastal Bend community gathered at Cole Park Pier to walk in support of lupus patients, raise awareness and honor those ...
Could a treatment  that has success against cancer, also help cure autoimmune disease? Dr. Alicia Leiberman, MD, MS, a ...